Citadel Advisors’s Incannex Healthcare Limited Common Stock IXHL Stock Holding History

Citadel Advisors’s Portfolio IXHL Stock Details IXHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$38.9K	Buy	+10,349	New	+$37.8K	﹤0.01%	13234
2025 Q2	–	Sell	-3,429	Closed	-$69.6K	–	13805
2025 Q1	$69.6K	Buy	+3,429	New	+$149K	﹤0.01%	11918
2024 Q4	–	Sell	-805	Closed	-$48.1K	–	14941
2024 Q3	$48.1K	Buy	+805	New	+$49.7K	﹤0.01%	11957
2024 Q2	–	Sell	-458	Closed	-$49.3K	–	14853
2024 Q1	$49.3K	Hold	458	–	–	﹤0.01%	12182
2023 Q4	$63.7K	Buy	+458	New	+$59.7K	﹤0.01%	11516
2022 Q2	–	Sell	-100	Closed	-$110K	–	13488
2022 Q1	$110K	Buy	+100	New	+$165K	﹤0.01%	12183

Other funds holding IXHL

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Citadel Advisors's IXHL Position: Q2 2026 in Review

Citadel Advisors opened a new position in Incannex Healthcare Limited Common Stock (IXHL) in Q2 2026: 10,349 shares worth $38.9K. The stake represents ﹤0.01% of the portfolio and ranks #13234 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in IXHL as recently as Q1 2025.

Citadel Advisors first reported a position in IXHL in Q1 2022 and has held it in 6 quarters since. The position peaked at $110K in Q1 2022. 15 funds tracked by Wall St. Rank hold IXHL as of Q2 2026.

Citadel Advisors held 10,349 shares of Incannex Healthcare Limited Common Stock worth $38.9K as of Q2 2026.
Incannex Healthcare Limited Common Stock was a new Citadel Advisors position in Q2 2026.
Incannex Healthcare Limited Common Stock made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13234 holding.
Citadel Advisors first reported a position in Incannex Healthcare Limited Common Stock in Q1 2022 and has held it in 6 quarters since.
Citadel Advisors's Incannex Healthcare Limited Common Stock position peaked at $110K in Q1 2022.
15 funds tracked by Wall St. Rank held Incannex Healthcare Limited Common Stock as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.